3D reflectors help boost data rate in wireless communications

Researchers developed a semiconductor chip that will enable ever-smaller devices to operate at the higher frequencies needed for future 6G communication technology.

Stand by your group: Loyalty can blur ethics line

Calling for loyalty to a group, rather than to an individual, was more effective in eliciting followers’ compliance with unethical requests, Johnson School researcher Angus Hildreth found.

Great horned owl comes to live Bird Cams project

Athena, a great horned owl nesting in Texas, is poised to become the next international avian superstar via a Cornell Lab of Ornithology Bird Cam.

Women entrepreneurs grow resources in Bangladesh

Feed the Future Insect-Resistant Eggplant Partnership program helps women in Bangladesh start plant nurseries and gain control over their finances.

Emerging salmonella variety in dairy cows worsens antimicrobial resistance

A study of more than 5,000 salmonella bacteria isolated over 15 years from dairy cattle samples in the Northeast reveals a significant increase in resistance to the antimicrobial medications ampicillin, florfenicol and ceftiofur.

Citizens often act against self-interest in granting police consent

New ILR School research suggests that obtaining true consent is difficult because most people are compliant and struggle to say “no.”

Student-made wave converters aim to seize the sea’s energy

Two Cornell Engineering undergraduates are working to make arrays of wave energy converters – devices catch the waves and turn them into electricity – and move the technology closer to actuality.

Ice shell thickness reveals water temp on ocean worlds

Decades before any probe dips a toe – and thermometer – into the waters of distant ocean worlds, Cornell astrobiologists have devised a way to determine ocean temperatures based on the thickness of their ice shells, effectively conducting oceanography from space.

Drug-resistant TB responds rapidly to bedaquiline-based therapy

Patients who have drug-resistant tuberculosis have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine.